These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1786109)

  • 1. Anti-LFA-1 antibody as immunosuppressive reagent in transplantation.
    Fischer A
    Chem Immunol; 1991; 50():89-97. PubMed ID: 1786109
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of bone marrow and cardiac graft rejection in an H-2 haplotype disparate mouse combination by an anti-LFA-1 antibody.
    Cavazzana-Calvo M; Sarnacki S; Haddad E; De Coene C; Calise D; Yvon E; Cerf-Bensussan N; Fischer A
    Transplantation; 1995 Jun; 59(11):1576-82. PubMed ID: 7778173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potential immunosuppressive effect of anti-lymphocyte function-associated antigen-1 monoclonal antibody on islet transplantation.
    Gotoh M; Fukuzaki T; Monden M; Dono K; Kanai T; Yagita H; Okumura K; Mori T
    Transplantation; 1994 Jan; 57(1):123-6. PubMed ID: 7904780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
    Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
    Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice.
    Berney T; Pileggi A; Molano RD; Poggioli R; Zahr E; Ricordi C; Inverardi L
    Transplantation; 2003 Dec; 76(12):1669-74. PubMed ID: 14688513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose dependent immunosuppressive effects of antibodies to ICAM-1 and LFA-1 on hepatic allografts.
    Harihara Y; Sugawara Y; Inoue K; Kubota K; Bandai Y; Makuuchi M; Miyasaka M
    Transplant Proc; 1996 Jun; 28(3):1794-5. PubMed ID: 8658886
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-adhesion (anti-ICAM-1 and anti-LFA-1) therapy in a rat pancreas transplantation model.
    Kawabe A; Kimura T; Suzuki H; Suzuki K; Harada Y
    Transplant Proc; 1996 Jun; 28(3):1808-11. PubMed ID: 8658893
    [No Abstract]   [Full Text] [Related]  

  • 8. Blocking of ICAM-1 and LFA-1 in rat liver transplantation.
    Degawa H; Watanabe K; Uchida H; Nagao T; Tomikawa S; Beck Y; Nomura Y; Ichikawa N; Ando Y; Kikuchi K; Ito S
    Transplant Proc; 1996 Jun; 28(3):1362-3. PubMed ID: 8658695
    [No Abstract]   [Full Text] [Related]  

  • 9. Biological reagents for immunosuppressants.
    Soulillou JP
    Transplant Proc; 1995 Feb; 27(1):106-8. PubMed ID: 7878803
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of exogenous IL-2 on tolerance induction by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies.
    Isobe M; Suzuki J; Yamazaki S; Sekiguchi M
    Transplant Proc; 1996 Apr; 28(2):1045-6. PubMed ID: 8623222
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction of transplantation tolerance by treatment with ICAM-1 antisense oligonucleotides and anti-LFA-1 monoclonal antibodies.
    Stepkowski SM; Tu Y; Condon TP; Bennett CF
    Transplant Proc; 1995 Feb; 27(1):113. PubMed ID: 7878822
    [No Abstract]   [Full Text] [Related]  

  • 12. Potent immunosuppressive effect of anti-LFA-1 monoclonal antibody on islet allograft rejection.
    Nishihara M; Gotoh M; Fukuzaki T; Ohta Y; Monden M; Yagita H; Okumura K; Miyasaka M; Mori T
    Transplant Proc; 1995 Feb; 27(1):372. PubMed ID: 7879025
    [No Abstract]   [Full Text] [Related]  

  • 13. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with anti-VLA-4 and LFA-1 monoclonal antibodies prolongs intraportal rat islet allograft survival.
    Yang H; Issekutz TB; Wright JR
    Transplant Proc; 1994 Dec; 26(6):3325-6. PubMed ID: 7998156
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of unresponsiveness to islet allograft by anti-LFA-1 monoclonal antibody treatment.
    Gotoh M; Fukuzaki T; Dono K; Wada H; Kanai T; Monden M; Yagita H; Okumura K; Mori T
    Transplant Proc; 1993 Feb; 25(1 Pt 2):973-4. PubMed ID: 8442286
    [No Abstract]   [Full Text] [Related]  

  • 16. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival.
    Grazia TJ; Gill RG; Gelhaus HC; Doan AN; Sleater ML; Pietra BA
    J Heart Lung Transplant; 2005 Sep; 24(9):1410-4. PubMed ID: 16143264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolongation of hepatic allograft survival with antibodies to ICAM-1 and LFA-1.
    Harihara Y; Sakamoto H; Sanjo K; Otsubo O; Watanabe G; Idezuki Y
    Transplant Proc; 1994 Aug; 26(4):2258. PubMed ID: 7915063
    [No Abstract]   [Full Text] [Related]  

  • 18. Monoclonal antibodies against ICAM-1 and LFA-1 (CD11A) induce specific tolerance to peripheral nerve allograft in rats.
    Nakao Y; Mackinnon SE; Mohanakumar T; Miyasaka M; Nakayama K; Nakafusa Y; Horiuchi Y; Yabe Y
    Transplant Proc; 1995 Feb; 27(1):373-7. PubMed ID: 7879026
    [No Abstract]   [Full Text] [Related]  

  • 19. [Selective immunosuppression with monoclonal antibodies against ICAM-1 and LFA-1 with FK 506 after experimental small intestine transplantation in the rat].
    Gasser M; Otto C; Timmermann W; Gassel HJ; Ulrichs K; Thiede A
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):595-9. PubMed ID: 14518324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-leucocyte function-associated antigen-1 antibodies inhibit T-cell activation following low-avidity and adhesion-independent interactions.
    Gorochov G; Gross G; Waks T; Eshhar Z
    Immunology; 1993 Aug; 79(4):548-55. PubMed ID: 8406579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.